↓ Skip to main content

Botulinum toxin injections for adults with overactive bladder syndrome

Overview of attention for article published in this source, December 2011
Altmetric Badge

Mentioned by

2 news outlets
2 blogs
1 policy source
1 X user
4 Wikipedia pages


190 Dimensions

Readers on

173 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Botulinum toxin injections for adults with overactive bladder syndrome
Published by
John Wiley & Sons, Ltd, December 2011
DOI 10.1002/14651858.cd005493.pub3
Pubmed ID

Duthie, James B, Vincent, Michael, Herbison, G Peter, Wilson, David Iain, Wilson, Don


Overactive bladder syndrome (OAB) is a common condition with a significant negative impact on quality of life characterised by urgency with or without urge incontinence, frequency and nocturia.  Intravesical botulinum toxin is being increasingly used to treat severe overactive bladder refractory to standard management.  An increasing body of literature is forming that supports this technique as effective, well tolerated, and safe.  This review is a substantial update of the 2007 review of the same title.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Belgium 1 <1%
Brazil 1 <1%
Unknown 170 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 15%
Student > Bachelor 19 11%
Researcher 17 10%
Student > Ph. D. Student 17 10%
Other 13 8%
Other 38 22%
Unknown 43 25%
Readers by discipline Count As %
Medicine and Dentistry 79 46%
Nursing and Health Professions 10 6%
Agricultural and Biological Sciences 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Social Sciences 5 3%
Other 23 13%
Unknown 46 27%